Vet360 Vet360 Vol 05 Issue 04 - Page 9

Sponsored by Annual Business Congress . 29 & 30 October - Johannesburg 25 & 26 October - Cape Town Institute of Veterinary Practice Development Manage and Improve the Performance of your Veterinary Business In association with BUSINESS ACADEMY DAY 1 Growing your practice - Dr Rourke Crosson Managing the financial performance of a Vet Business - Andrew Christie Capital Expenditure Decisions - Andrew Christie Business entity type and implications - Phia van der Spu Estate planning - Phia van der Spuy 8 Practical Facebook Tips and Ideas for Vets - Johan Mouton 10 Instagram Best Practices for Vets - Johan Mouton Advertising rules - SAVC - Myths and Facts - John Adam DAY 2 Help - Veterinary staff are different! Managing vet employees - Andrew Butters 25 & 26 October 2018, Cape Town Help - Veterinary staff are different! Motivating vet employees 29 & 30 October 2018, Johannesburg - Andrew Butters Creating KPIs for a Veterinary Business in SA (and using them) - Andrew Christie Is a complete veterinary service relevant in the marketplace - Nadine Mayers The future of the Veterinary Industry - Dr Alan Robinson Creating Value in Human and Animal Health - Dr Pieter Vervoort & Dr Hannah Aldean Forecast for the SA Economy - Nicky Weimer To register or for information: Autoimmune Skin Disease in Dogs and Cats Prof. Andrew Leisewitz Companion Animal Clinical Studies Andrew Leisewitz graduated with his BVSc degree in 1987. This was followed by an Hons in 1991, an MMedVet(Med) in 1995 and a PhD in 2006. Andrew was appointed as a senior lecturer in the then Department of Medicine at Onderstepoort in June 1990. He is been a full professor of Companion Animal Clinical Studies since 1995 and is a diplomat of the European College of Veterinary Internal Medicine – Companion Animals. He has worked as a specialist clinician in the Onderstepoort Veterinary Academic Hospital for nearly 30 years. He runs a dermatology referral clinic within the Onderstepoort Veterinary Hospital and in a Johannesburg based specialist referral hospital. He has initiated a dermatology specific internship at the Faculty which will run for the first time in 2019. He is an active teacher of undergraduate and post graduate veterinary students, and is a frequently invited speaker and presenter of continuing education for the profession in the sub-region. His research focusses on understanding the mechanisms of infectious disease making use of canine babesiosis and distemper virus infection as models for this work. This is a unique and less common group of disease in which the body’s own immune system turns on self – which in this case are components of the skin. We will discuss the diseases in two broad categories, namely those diseases that are vesicular or pustular in nature and those diseases that are not characterised be vesicles or pustules. We will spend most of discussion time on the most common of these disease. Discoid lupus is probably the most common autoimmunity seen in dogs. It is not a vesicular disease but is characterised most commonly by nasal depigmentation. Pemphigus foliaceus is probably the second most common autoimmune skin disease in dogs and the most common in cats. It is characterised by superficial cleft formation (resulting in vesicles and then pustules and then crusts) in the epidermis and typically affects the face and feet but may involve the trunk as well. Other forms of pemphigus are significantly less common and result in cleft formation deeper in the epidermis and have a more severe disease presentation and poorer outcome. Pemphigus may also be triggered by idiosyncratic reactions to drugs as well as by neoplasia. Other even less common dermal auoimmunities include lupoid onychodystrophy, erythema multiforme and toxic epidermal necrolysis. Systemic autoimmunities such as systemic lupus erythematosus may also result in skin lesions. The corner stone of diagnosis rests on histology of well chosen, properly timed and atraumatically collected skin biopsies. Treatment usually depends on glucocorticoid induced immunosuppression. This treatment is frequently augmented through the addition of other systemic immunosuppressive agents. Prognosis varies widely depending on the specific disease diagnosed. PRICE: Free (use code AUTOIMMUNE) DATE: 24 October 20:00 CAT REGISTER: Use autoimmune as password for live webinar Shaping the future of animal health